Fecal Calprotectin (FC)
Role of Fecal Calprotectin in Diagnosis and Follow up of Hepatic Encephalopathy
5
A New Immunofluorescence Assay for Fecal Calprotectin Distinguishes Inflammatory Bowel Disease from Functional Bowel Disease
10
Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection
5
Fecal calprotectin levels are higher in rural than in urban Chinese infants and negatively associated with growth
6
VALUE OF FECAL CALPROTECTIN AS A NON-INVASIVE MARKER DIFFERENTIATING ORGANIC FROM FUNCTIONAL BOWEL DISEASES
6
Clinical outcomes at 12 months and risk of inflammatory bowel disease in patients with an intermediate raised fecal calprotectin : a ‘real world’ view
8
A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis
9
Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes
7
Diagnostic Value of Fecal Calprotectin and Serum MMP 9 in Diagnosing Disease Activity of Ulcerative Colitis
11
A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin
12
Fecal Calprotectin and Transforming Growth Factor-b1 in the Evaluation of Disease Activity in Patients with Ulcerative Colitis
9
Fecal Calprotectin Level of Breast Milk-Formula vs Formula Feeding in Preterm and Low Birth Weight Neonates with Necrotizing Enterocolitis
6
Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn’s disease
9
Can Giardia Infection Impair the Diagnostic Level of Fecal Calprotectin in Patients with Inflammatory Bowel Disease? A Case Report
5
Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study
9
Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial
9
Fecal Calprotectin as an Activity Marker of Inflammatory Bowel Disease in Children
8
Fecal calprotectin in inflammatory bowel disease
9
Fecal Occult Blood and Fecal Calprotectin as Point-of-Care Markers of Intestinal Morbidity in Ugandan Children with Schistosoma mansoni Infection
9
Fecal calprotectin and lactoferrin in comparison with colonoscopy in differentiating of inflammatory bowel disease from irritable bowel syndrome
6